Anti-CD20 Therapy Reduces Microglial Activation and Lesion Volume in Focal Models of Pattern I and Pattern II Multiple Sclerosis
Main Authors: | Leppert, D, Campbell, S, Seneca, N, Warren, E, Balazs, M, Anthony, D |
---|---|
Format: | Conference item |
Published: |
2012
|
Similar Items
-
Anti-CD20 therapy reduces microglial activation and lesion volume in focal models of pattern I and pattern II multiple sclerosis
by: Anthony, D, et al.
Published: (2012) -
Anti-CD20 therapy reduces lesion volume and activated microglia in rodent models of multiple sclerosis
by: Seneca, N, et al.
Published: (2012) -
Anti-CD20 therapy down-regulates lesion formation and microglial activation in pattern I and pattern II rat models of multiple sclerosis
by: Anthony, D, et al.
Published: (2014) -
Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis
by: Anthony, D, et al.
Published: (2009) -
Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.
by: Anthony, D, et al.
Published: (2014)